GlossaryTopic

Pharmaceutical Traceability

Term 174 of 268 · Topic

In one sentence

Pharmaceutical traceability is the ability to follow each medicine by its serialized unit (lot, expiration date, serial number) across the entire chain, from the manufacturer to the patient, to guarantee authenticity and enable recalls.

Reviewed by Juan Manuel Garrido

Co-founder of VantegrateLinkedIn

Pharmaceutical Traceability definition

Pharmaceutical traceability is the ability to identify and follow each unit of medicine (box, bottle or blister pack) across the entire supply chain, from manufacturing to the point of dispensing, recording every change of custody. Unlike general product traceability, it works at the level of the individual serialized unit, not just by lot, because health regulations require it and because a mistake can affect a patient's health.

Each package carries a unique identifier (a GTIN code plus a serial number, lot and expiration date) that is reported to a national regulatory system at every movement: leaving the plant, arriving at the distributor, the sale to the pharmacy and dispensing. In Argentina, this takes the form of the Sistema Nacional de Trazabilidad (National Traceability System) run by ANMAT, Argentina's drug regulator, where drug wholesalers, pharmacies and drug manufacturers report transactions online. It is a core operational requirement in the industry, and part of what we address in Pharmaceutical.

The end goal is threefold: block counterfeiting and theft, enable surgical market withdrawals (recalls) when a lot turns out defective, and provide visibility into where each product is in real time.

Why pharmaceutical traceability is different

In most industries, knowing the lot is enough. Not in medicines: regulation requires tracking the individual unit, because every package can end up in a person's hands and because the black market for counterfeit or stolen medicines moves enormous sums worldwide (according to the WHO, at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified). That turns traceability into a legal obligation, not an optional best practice.

The mechanism rests on three linked operations. Serialization assigns each package a unique serial number that, together with the GTIN, lot and expiration date, forms its identity. Aggregation links those units to the case that holds them and the case to the pallet, so that scanning a single higher-level code reveals everything inside (a parent-child relationship). Event reporting notifies the regulatory system of every change of custody: who had it, who receives it and when.

How it works in Argentina

ANMAT's Sistema Nacional de Trazabilidad requires every link in the chain to report transactions online. A drug manufacturer reports the shipment of a serialized lot; the drug wholesaler confirms receipt; the pharmacy reports the intake and, finally, the dispensing to the patient. If a transaction does not match (for example, the pharmacy receives a unit the distributor never reported as shipped), the system raises an alert: there may be a diversion, a theft or a counterfeit. That automatic reconciliation between what was declared and what was received is the heart of the control.

What problems it solves, with a concrete example

Imagine a drug manufacturer in Buenos Aires that detects that a lot of an injectable drug was released with a potency deviation. Without unit-level traceability, the recall would be blind: all the product would have to be pulled from the market. With serialization and aggregation, the team identifies exactly which serial numbers from that lot reached which drug wholesalers and pharmacies, issues a targeted recall and verifies that every unit came back. What would take weeks and cost a fortune is resolved in days, and proven to the health authority with evidence.

Main benefits of a well-implemented system:

  • Patient safety: counterfeit, stolen or expired products are blocked from entering the legal supply chain.
  • Precise recalls: only the affected lot is withdrawn, without freezing the rest of the stock or losing legitimate sales.
  • Regulatory compliance: you comply with ANMAT and avoid penalties, without building manual reports.
  • Inventory control: you gain stock visibility by expiration date, which reduces shrinkage from products that expire on the shelf.
  • Reputation and reimbursements: health insurers and private health plans (obras sociales and prepagas) require traceability to reimburse high-cost medicines.

Pharmaceutical traceability vs general traceability

It should not be confused with traceability of ordinary products or with the cold chain, which is a complement (not all traceability involves temperature control, although for biologics it does).

AspectPharmaceutical traceabilityGeneral traceability
GranularitySerialized unit (unique serial number)Lot or pallet
RequirementRequired by law (ANMAT, health regulator)Voluntary or optional by sector
ReportingEvent by event to a government systemInternal or between trading partners
Risk if it failsPatient health, legal penaltiesOperational or commercial loss
VerificationMandatory end-to-end reconciliationPer company policy

Common mistakes when implementing it

The first is treating it as a labeling project rather than a data project: serializing the boxes without a system that reconciles transactions leaves half the job undone. The second is ignoring aggregation, which forces the warehouse to scan package by package and makes the operation impractical at scale. The third is not integrating traceability with the ERP and the inventory system, which creates two versions of the truth about stock. And the fourth, very common, is leaving regulatory reconciliation for month-end in spreadsheets: inconsistencies are discovered late, when the source of the diversion can no longer be traced.

Share
Frequently asked questions

FAQs about Pharmaceutical Traceability

What is pharmaceutical traceability?

Pharmaceutical traceability is the ability to identify and follow each unit of medicine across the entire supply chain, from manufacturing to dispensing to the patient. It works at the level of the individual serialized unit (with a unique serial number, lot and expiration date), not just by lot, because health regulations require it and because a defective or counterfeit product can affect people's health. Its goal is to guarantee authenticity, enable precise market withdrawals and provide real-time visibility of the product.

How does drug traceability work in Argentina?

In Argentina it works through ANMAT's Sistema Nacional de Trazabilidad (National Traceability System). Each link in the chain (drug manufacturer, drug wholesaler and pharmacy) must report every transaction of the serialized product online: the shipment from the plant, receipt by the distributor, intake at the pharmacy and final dispensing to the patient. The system automatically reconciles what was declared against what was received at each movement. When a transaction does not match, for example when a pharmacy receives a unit that nobody reported as shipped, an alert is triggered that may indicate a diversion, a theft or a counterfeit.

What is the difference between serialization and aggregation?

Serialization is assigning each individual package a unique serial number that, together with the product code, lot and expiration date, makes up its one-of-a-kind identity. Aggregation is linking those serialized units to the case that holds them, and that case to the pallet, creating a parent-child hierarchy. The practical difference is huge: thanks to aggregation, scanning a single code on the case or pallet automatically reveals all the units inside, without having to open and scan package by package in the warehouse.

Why is traceability important for a drug recall?

It is essential because it makes the market withdrawal surgical instead of massive. When a drug manufacturer detects a lot with a quality problem, unit-level traceability tells it exactly which serial numbers from that lot reached which drug wholesalers and pharmacies. It can then issue a recall targeted only at the affected units, verify that each one comes back and prove it to the health authority with evidence. Without traceability, the recall would be blind, much slower and more expensive, and would force the company to collect sound product along with the defective one.

What happens if a medicine has no traceability?

A medicine without valid traceability cannot legally circulate in the formal supply chain. Drug wholesalers and pharmacies should not receive or dispense it, and health insurers or private health plans may refuse to reimburse its cost, especially for high-value medicines. In addition, the lack of traceability is precisely the gap through which counterfeit, stolen or expired products get in. For the company that fails to comply, it means penalties from the regulator, since reporting transactions is a legal obligation and not an optional practice.

When is unit-by-unit serialization not worth it?

When the product is not covered by the regulation and its risk does not justify it. Serializing every package of a low-value, over-the-counter line adds equipment, printing and rework costs with no real health benefit: there, control by lot and expiration date is enough. Unit-level serialization pays off for high-value, refrigerated or counterfeit-prone products, where being able to isolate individual units changes the outcome.

This, applied to your regulated chain

Traceability, cold chain and regulatory documentation, with the evidence ready when the audit arrives instead of assembled in a rush. Tell us what your regulator requires.

Keep exploring

Related terms

Your industry

Pharmaceutical industry

Traceability, cold chain and regulatory documentation, with evidence ready when the audit arrives.

How we solve it in the pharmaceutical industry
The full suite
Now that you know what it is, see how it gets solved

Five AI products that work on top of the CRM you already use. They don't replace your system: they add the layer you do by hand today.